Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer
PaperCitations, authors & open-access status
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 153 citations, 2024 year and hybrid oa status.
153
Citations
2024
Year
hybrid
OA Status